Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology
Panoramica dello studio
Stato
Stato
Condizioni
Condizioni
Intervento / Trattamento
Intervento / Trattamento
Descrizione dettagliata
Tipo di studio
Tipo di studio
Iscrizione (Effettivo)
Iscrizione
Fase
Fase
- Fase 2
- Fase 1
Contatti e Sedi
Luoghi di studio
-
-
Arkansas
-
No. Little Rock, Arkansas, Stati Uniti, 72114-1706
- Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
-
-
Criteri di partecipazione
Criteri di ammissibilità
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
- Veterans will be eligible if they are 18 years old or older,
- speak and understand English,
- are patients in the Central Arkansas Veterans Healthcare System Primary Care-Mental Health Integration,
and have a current diagnosis of depression
- major depressive disorder, 296.2x and 296.3x
- dysthymic disorder, 300.4
- depressive disorder not otherwise specified, 311
and/or anxiety
- panic disorder without agoraphobia, 300.01
- panic disorder with agoraphobia, 300.21
- specific phobia, 300.29
- social phobia, 300.23
- obsessive-compulsive disorder; 300.3
- posttraumatic stress disorder, 309.81
- acute stress disorder, 308.3
- generalized anxiety disorder, 300.02
- anxiety disorder not otherwise specified, 300.00
- We considered enrolling only those Veterans diagnosed with mild-to-moderate depression, but chose to include a range of anxiety and depression-related disorders in order to reflect the population of Veterans seen in Primary Care-Mental Health Integration.
- Additionally, Problem Solving Therapy is designed to treat a range of stress-related problems, including both anxiety and depressive disorders.
- Veterans taking prescribed anxiolytics or anti-depressants will be eligible if they are on a stable medication regimen.
Exclusion Criteria:
- Exclusionary criteria include any current suicidal ideation,
- substance dependence diagnosis and current use,
- any psychotic spectrum diagnoses or
- inability to provide informed consent.
- Diagnosis will be confirmed by chart review and Mini International Neuropsychiatric Interview.
- Acute suicidal ideation will be determined by the assessing or treating clinician.
- During the baseline and follow-up interviews, any Veteran who endorses a "1" or higher on item # 21 on the Depression Anxiety and Stress Scale "I feel that life isn't worthwhile" or item # 9 on the Patient Health Questionnaire-9 "thoughts that you would be better off dead or of hurting yourself" will be asked follow-up questions on the suicide risk protocol (see appendix 3).
- Current substance or alcohol use will be determined by the alcohol and substance use modules of the Mini International Neuropsychiatric Interview.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Ricerca sui servizi sanitari
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Numero di armi
Armi e interventi
Gruppo di partecipanti / ArmGruppo di partecipanti / Arm |
Intervento / TrattamentoIntervento / Trattamento |
|---|---|
|
Sperimentale: Problem Solving Therapy plus Moving Forward (PST-MF)
All Veterans will receive a standard 6-session administration of Problem Solving Therapy (Nezu & D'Zurilla, 1999).
Session 1 will take place in-person during a scheduled appointment and will last for 1 hour.
Subsequent sessions will take place over the telephone and will last for approximately 30 minutes.
Participants in this arm will also receive the Moving Forward app for SmartPhones, which was adapted from Problem Solving Therapy to be used either as a standalone treatment or as an adjunct to other related therapies such as in-person Problem Solving Therapy or the Moving Forward website.
The phone content matches Problem Solving Therapy.
Benefits of the app include 24-hours accessibility of psychoeducational materials and worksheets.
|
All Veterans will receive a standard 6-session administration of Problem Solving Therapy (Nezu & D'Zurilla, 1999).
Session 1 will take place in-person during a scheduled appointment and will last for 1 hour.
Subsequent sessions will take place over the telephone and will last for approximately 30 minutes.
Participants in this arm will also receive the Moving Forward app for SmartPhones, which was adapted from Problem Solving Therapy to be used either as a standalone treatment or as an adjunct to other related therapies such as in-person Problem Solving Therapy or the Moving Forward website.
The phone content matches Problem Solving Therapy.
Benefits of the app include 24-hours accessibility of psychoeducational materials and worksheets.
|
|
Comparatore attivo: Problem Solving Therapy
All Veterans will receive a standard 6-session administration of Problem Solving Therapy (Nezu & D'Zurilla, 1999).
Session 1 will take place in-person during a scheduled appointment and will last for 1 hour.
Subsequent sessions will take place over the telephone and will last for approximately 30 minutes.
|
All Veterans will receive a standard 6-session administration of Problem Solving Therapy (Nezu & D'Zurilla, 1999).
Session 1 will take place in-person during a scheduled appointment and will last for 1 hour.
Subsequent sessions will take place over the telephone and will last for approximately 30 minutes.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Depression Anxiety and Stress Scale (DASS)
Lasso di tempo: 6 weeks, 12 weeks
|
The 7-item depression subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale.
Higher scores represent worse depression symptoms.
The 7-item anxiety subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale.
Higher scores represent worse anxiety symptoms.
The 7-item stress subscale on the Depression Anxiety and Stress Scale (DASS) is measured on a 0-42 scale.
Higher scores represent worse stress symptoms.
|
6 weeks, 12 weeks
|
Misure di risultato secondarie
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score
Lasso di tempo: 6 weeks, 12 weeks
|
The 12-item Short Form Health Survey-12-Veterans (SF-12 V) Mental Composite Score is rated on a 0-100 scale.
Higher scores represent better mental health functioning.
|
6 weeks, 12 weeks
|
|
Client Satisfaction Questionnaire (CSQ-8)
Lasso di tempo: 6 weeks
|
The 8-item Client Satisfaction Questionnaire (CSQ-8) is rated on an 8-32 scale.
Higher scores represent greater satisfaction with the intervention.
|
6 weeks
|
Collaboratori e investigatori
Sponsor
Sponsor
Investigatori
Investigatori
- Investigatore principale: Kathleen M Grubbs, PhD, Central Arkansas Veterans Healthcare System Eugene J. Towbin Healthcare Center, Little Rock, AR
Studiare le date dei record
Studia le date principali
Inizio studio
Inizio studio
Completamento primario (Effettivo)
Completamento primario
Completamento dello studio (Effettivo)
Completamento dello studio
Date di iscrizione allo studio
Primo inviato
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Stima)
Primo Inserito
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Stima)
Ultimo aggiornamento pubblicato
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
Altri numeri di identificazione dello studio
- PPO 13-122
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .